Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BNZI vs MAIA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MAIA Wins Head-to-Head Institutional Verdict (2–2 across 6 Pillars · 7–3 Matrix Metrics)

MAIA Overall Winner 6-Pillar Tally: BNZI 2 – 2 MAIA (2 Tie) Matrix Metrics: BNZI 3 – 7 MAIA

As of Nov 20, 2026, MAIA Biotechnology, Inc. (MAIA) is the stronger overall head-to-head candidate over Banzai International, Inc. (BNZI) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). BNZI carries a Unified Composite Score of 48.9/100 (HOLD) at $1.91 (N/M Forward P/E, -214.4% operating margin), whereas MAIA carries 37.6/100 (SELL) at $1.11 (1.2x Forward P/E, 0.0% operating margin).

  • Composite vs. Pillar Nuance: While BNZI currently prints a higher short-term Unified Composite Score (48.9/100 HOLD vs. MAIA 37.6/100 SELL), MAIA captures the overall institutional head-to-head verdict (7–3 matrix metrics and 2–2 across the 6 pillars) due to superior fundamental profitability (0.0% vs. -214.4% operating margin) and revenue trajectory (+0.0% vs. -20.2% YoY).
  • Technical & Structure Timing Caution: BNZI is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.5); meanwhile MAIA trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 48.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BNZI vs MAIA
BNZI NASDAQ
Banzai International, Inc. Class A Common Stock
Services-Prepackaged Software
$1.91
+7.91% 1D
Market Cap $5.9M
TTM Revenue $11M
Forward P/E N/M
Beta / 30D Vol 12.28β · 134% Vol
Unified Composite Score
48.9 / 100 HOLD
Tech 25.0 Fund 43.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -12.0%), weak momentum, RSI 42
RSI-14: 41.5 · SMA20: $2.18 · SMA50: $2.78
MAIA NYSE American Head-to-Head Winner
MAIA Biotechnology, Inc.
Pharmaceutical Preparations
$1.11
-2.63% 1D
Market Cap $68.5M
TTM Revenue N/A
Forward P/E 1.2x
Beta / 30D Vol 1.65β · 108% Vol
Unified Composite Score
37.6 / 100 SELL
Tech 40.0 Fund 38.0 Flow 50.0 Mom 44.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 49
RSI-14: 48.8 · SMA20: $1.11 · SMA50: $1.17

6-Pillar Scorecard Institutional Category Breakdown (BNZI 2 – 2 MAIA)

Columns: Metric · BNZI · MAIA
1. Valuation Multiples BNZI
Forward P/E N/M 1.2x
Trailing P/E 0.0x 1.2x
PEG Ratio N/M N/M
EV / Revenue 1.4x N/M
2. Growth & Scale MAIA
Revenue Growth (YoY) -20.2% +0.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $11M N/A
Market Cap $5.9M $68.5M
3. Profitability & Quality MAIA
Gross Margin 81.7% N/A
Operating Margin -214.4% 0.0%
Net Profit Margin -237.5% 0.0%
Return on Equity (ROE) -493.9% -341.5%
4. Balance Sheet & Cash Flow BNZI
Cash Generation (TTM) -$18M EBITDA -$20M
Cash Flow Margin N/A N/A
Net Cash / Leverage $9.7M Net Debt (1.22x D/E) $0.24 Book/Sh · -341.5% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Software - Application Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BNZI (3) vs MAIA (7)
Institutional Metric BNZI MAIA Criterion Row Edge
Market Capitalization
Scale
$5.9M $68.5M Larger Scale MAIA
Trailing P/E Ratio
Valuation
0.0x 1.2x Lower Multiple BNZI
Forward P/E Ratio
Valuation
N/M 1.2x Lower Multiple MAIA
Revenue Growth (YoY)
Growth
-20.2% +0.0% Higher Growth MAIA
Operating Margin (TTM)
Profitability
-214.4% 0.0% Higher Margin MAIA
Net Profit Margin
Profitability
-237.5% 0.0% Higher Margin MAIA
Return on Equity (ROE)
Capital Efficiency
-493.9% -341.5% Higher ROE MAIA
52-Week Range Position
Momentum
21% ($0–$8) 10% ($1–$3) Stronger Trend BNZI
Beta / 30D Volatility
Risk Regime
12.28β · 134% Vol 1.65β · 108% Vol Lower Realized Risk MAIA
Unified Institutional Score
Composite Signal
48.9 / 100 (HOLD) 37.6 / 100 (SELL) Higher Composite BNZI
Trailing 12M Revenue (USD)
Operating Scale
$11M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
81.7% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.4x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$18M EBITDA ($9.7M Net Debt (1.22x D/E)) -$20M ($0.24 Book/Sh · -341.5% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MAIA +33.77 pp
BNZI: -37.17% · MAIA: -3.4%
3M Horizon BNZI +762.6 pp
BNZI: +767.79% · MAIA: +5.19%
6M Horizon BNZI +104.18 pp
BNZI: +70.54% · MAIA: -33.64%
1Y Horizon BNZI +3.5 pp
BNZI: +57.85% · MAIA: +54.35%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BNZI vs MAIA. Trailing 12-month operating profitability (BNZI -214.4% vs MAIA 0.0%) and valuation multiples (BNZI N/M vs MAIA 1.2x Forward P/E) are benchmarked directly in Pillar 4 below.

BNZI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$11M
Gross Margin81.7%
Op. Margin-214.4%
ROE / Fwd P/E-493.9% · N/M
MAIA ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-341.5% · 1.2x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BNZI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BNZI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MAIA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MAIA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BNZI Moat Profile Cyclical / Execution-Driven Positioning
Software - Application Operator
Competes within the Software - Application value chain with $5.9M market capitalization and -214.4% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
MAIA Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $68.5M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ BNZI vs MAIA Key Questions & Quantitative Answers

As of Nov 20, 2026, MAIA Biotechnology, Inc. (MAIA) is the stronger overall head-to-head candidate over Banzai International, Inc. (BNZI) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). BNZI carries a Unified Composite Score of 48.9/100 (HOLD) at $1.91 (N/M Forward P/E, -214.4% operating margin), whereas MAIA carries 37.6/100 (SELL) at $1.11 (1.2x Forward P/E, 0.0% operating margin). Composite vs. Pillar Nuance: While BNZI currently prints a higher short-term Unified Composite Score (48.9/100 HOLD vs. MAIA 37.6/100 SELL), MAIA captures the overall institutional head-to-head verdict (7–3 matrix metrics and 2–2 across the 6 pillars) due to superior fundamental profitability (0.0% vs. -214.4% operating margin) and revenue trajectory (+0.0% vs. -20.2% YoY). Technical & Structure Timing Caution: BNZI is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.5); meanwhile MAIA trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 48.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

MAIA leads the Growth & Scale pillar: BNZI posts -20.2% YoY revenue growth and +0.0% YoY earnings growth on $11M TTM revenue (81.7% gross margin, -214.4% operating margin), compared with MAIA at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, BNZI generates $11M in USD-normalized revenue versus N/A for MAIA. In operating R&D and SG&A reinvestment, BNZI deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for MAIA.

BNZI screens cheaper on headline valuation multiples. BNZI trades at N/M Forward P/E, 0.0x Trailing P/E, N/M PEG, and 1.4x EV/Revenue (unreported EBITDA margin), whereas MAIA trades at 1.2x Forward P/E, 1.2x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BNZI (-493.9% ROE) versus MAIA (-341.5% ROE) capital efficiency.

In options market volatility and institutional positioning, BNZI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (12.28β · 134% Vol realized risk). By comparison, MAIA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.65β · 108% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.